NCT07107685 Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care.
| NCT ID | NCT07107685 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Osteoarticular Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-09-24 |
| Primary Completion | 2026-09-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-09-24 with a primary completion date of 2026-09-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational, retrospective, multicenter study based on the use of demographic, clinical and biological data from deceased patients admitted between 2018 and 2022 to critical care with a principal or associated diagnosis of joint prosthesis infection. Data from this study will be combined with that from the OASIS study (APHP241174/ ID-RCB: 2024-A01769-38) concerning osteoarticular sepsis on prosthetic material in critical care of living patients. The aim of this study is to improve our knowledge of the profile, care trajectories and outcomes of patients hospitalized in critical care in the context of osteoarticular material sepsis. The results of the study could help identify at-risk populations and improve management strategies for patients with osteoarticular sepsis.
Eligibility Criteria
Inclusion Criteria: * Patient aged 18 years or older. * Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022, lasting at least 48 hours, with a prosthetic joint infection (hip, knee, or shoulder prosthesis infection) as the primary or associated diagnosis. * Deceased patient who had not refused data processing. Exclusion Criteria: * Infection involving osteosynthesis material * Infection involving spinal instrumentation * Patient with multiple infected prostheses * Recurrence of prosthetic infection with the same microorganism as a previous episode * Patient under legal protection * Pregnant or breastfeeding patient * Patient deprived of liberty
Contact & Investigator
Carine PARE
STUDY DIRECTOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT07107685 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarticular Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07107685 currently recruiting?
Yes, NCT07107685 is actively recruiting participants. Contact the research team at benjamin.soyer@aphp.fr for enrollment information.
Where is the NCT07107685 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07107685 clinical trial?
NCT07107685 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Carine PARE at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 150 participants.